Biotie Therapies' IPO - II Round

Biotie Therapies raised a round of funding on June 11, 2015. Investors include Public.

Biotie is a specialized drug development company focused on the development of drugs for neurodegenerative and psychiatric disorders (e.g. Parkinson's disease, Alzheimer's disease and other cognitive …

Articles about Biotie Therapies' IPO - II Round: